In this model, semaglutide exerted protective effects on liver inflammation, fibrosis, and ROS accumulation, as well as the activated GLP-1R signaling pathway, leading to the inhibition of ubiquitin–proteasome system (UPS)-mediated proteolysis and to the promotion of myocyte myogenesis [69]. The gene discussed is GLP1R; the disease is Hepatitis.